Circulating vaccine-derived poliovirus type 1 confirmed in Papua New Guinea

Outbreak response to be launched to stop further spread of the virus

A child is protected from lifelong polio paralysis through OPV vaccination. © WHO
A child is protected from lifelong polio paralysis through OPV vaccination. © WHO

Following identification last month of an acute flaccid paralysis (AFP) case from which vaccine-derived poliovirus type 1 (VDPV1) had been isolated, genetic sequencing of two VDPV1s from two non-household contacts of the AFP case has now confirmed that VDPV1 is circulating and is being officially classified as a  ‘circulating’ VDPV type 1 (cVDPV1).

The National Department of Health (NDOH) of Papua New Guinea is closely working with the GPEI partners in launching a comprehensive response. Some of the immediate steps include conducting large-scale immunization campaigns and strengthening surveillance systems that help detect the virus early. These activities are also being strengthened in neighboring provinces.

The GPEI and its partners are continuing to work with regional and country counterparts and partners in supporting the Government of Papua New Guinea and local public health authorities in conducting a full field investigation, risk assessment and to support the planning, implementation and monitoring of the outbreak response.

For more information:

Contact Oliver Rosenbauer, Communications Officer, Global Polio Eradication Initiative, tel: +41 79 500 6536

Related resources


Related News

   25/01/2023
This snapshot shows all polio events and outbreaks that occurred/were ongoing in the Eastern Mediterranean Region (EMR) in 2022
   16/01/2023
This is the target year for interrupting all remaining poliovirus transmission globally, both in the remaining endemic countries and in outbreak settings.
   12/01/2023
Dr Hamid Jafari, Director of Polio for the WHO’s Eastern Mediterranean Region, reflects on his time eradicating polio in India and what lessons we can take from this to address the final challenges for achieving eradication in Afghanistan and Pakistan.
   08/12/2022
As 2022 draws to a close, independent technical bodies from key epi-centres dive deep on what it will take to achieve success in 2023
   25/10/2022
We are close to making polio the second human disease to be eradicated, but what will it take to finally consign this killer disease to the history books?